ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
批准号:
6884632
负责人:
VALERIE ASKANAS
金额:
$31.28万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2010-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
EXCEED THE SPACE PROVIDED. Sporadic inclusion-body myositis (s-IBM) is a progressive, highly debilitating, and the most common ¿nuscle disease of older persons (over age 60). An intriguing aspect of s-IBM is that its muscle fiber phenotype has features remarkably similar to those of Alzheimer Disease (AD) brain ("IBM-AD phenotype"), including abnormal accumulations of: 3-amyloid precursor protein (¿APP) and of several other proteins accumulated in AD brain. Another similarity to AD is the presence of hereditary forms, termed "hereditary inclusion-body nyopathies (h-IBM)", which clinically are manifest earlier than s-IBM, but have a muscle-fiber phenotype identical to, though apparently somewhat less advanced than, that of s-IBM. Similarly to AD brain, abnormal nuscle fibers of s- and h-IBM have evidence ofoxidative stress. Abnormalaccumulation of (3APP epitopes appears toprecede other abnormalities in s- and h-IBM muscle, in vivo and in vitro. Therefore, we propose that JAPP overexpressiom (whole molecule and/or A(3fragment) in the milieu of aged (s-IBM) or genetically- abnormal adult (h-IBM) muscle fibers causes molecular disturbances leading to oxidative stress, which then causes the IBM-specific vacuolar muscle-fiber degeneration and expression of the IBM-AD phenotype. This >roposal addresses the schedule, and therefore possible mechanisms, of early steps in the pathogenic cascade. It involves: 1)three long-term culture models, namely, a) a spontaneous model utilizing cultures of biopsied muscle of h-IBM; b) a spontaneous model utilizing cultures of s-IBM muscle; and c) an induced model utilizing matured cultured normal human muscle fibers into which is transferred the (3APP gene; and 2) an induced in vivo aged-rat nodel based on transfer of the 3APP gene into aged-rat gastrocnemius muscle. Anti-oxidant treatments, including estrogens, will be done on abnormal cultures. We postulate that in vivo aging of the involved tissues may be a predisposing factor(s) in both the IBM's and the ADgroup, especially in the sporadic, more common, forms of each. Because our type of cultured spontaneous and induced models of the human tissue actually affected in the >atient are not available to study brain involvement in the AD's, possibly our results may provide important information relevant to the pathogenesis and treatment of the AD's. PERFORMANCE SITE ========================================Section End===========================================
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Novel cytoplasmic immunolocalization of RNA polymerase II in inclusion-body myositis muscle.
RNA 聚合酶 II 在包涵体肌炎肌肉中的新型细胞质免疫定位。
DOI:
10.1097/00001756-200107030-00010
发表时间:
2001
期刊:
Neuroreport
影响因子:
1.7
作者:
[Wilczynski,GM, Engel,WK, Askanas,V]
通讯作者:
Askanas,V
Myostatin and its precursor protein are increased in the skeletal muscle of patients with Type-II muscle fibre atrophy.
II 型肌纤维萎缩患者的骨骼肌中肌生长抑制素及其前体蛋白增加。
DOI:
--
发表时间:
2008
期刊:
Folia morphologica
影响因子:
1.2
作者:
[Wojcik,S, Nogalska,A, Engel,WK, Askanas,V]
通讯作者:
Askanas,V
DOI:
10.1111/j.1471-4159.2009.06461.x
发表时间:
2010-01
期刊:
Journal of neurochemistry
影响因子:
4.7
作者:
[Terracciano C, Nogalska A, Engel WK, Askanas V]
通讯作者:
Askanas V
DOI:
10.1097/nen.0000000000000196
发表时间:
2015-06
期刊:
Journal of neuropathology and experimental neurology
影响因子:
3.2
作者:
[Nogalska A, D'Agostino C, Engel WK, Cacciottolo M, Asada S, Mori K, Askanas V]
通讯作者:
Askanas V
DOI:
10.1016/j.neulet.2010.03.023
发表时间:
2010-05-03
期刊:
Neuroscience letters
影响因子:
2.5
作者:
[Nogalska A, Engel WK, Askanas V]
通讯作者:
Askanas V
共 13 条
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6448889
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2001
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6353435
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2000
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6318249
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2000
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6295391
-
项目类别:
-
资助金额:$33.2万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:2837339
-
项目类别:
-
资助金额:$23.04万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6948644
-
项目类别:
-
资助金额:$1.8万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6098054
-
项目类别:
-
资助金额:$33.2万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6294141
-
项目类别:
-
资助金额:$3.2万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6509651
-
项目类别:
-
资助金额:$33.84万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6629838
-
项目类别:
-
资助金额:$34.85万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6372344
-
项目类别:
-
资助金额:$32.88万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6168924
-
项目类别:
-
资助金额:$23.72万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6720867
-
项目类别:
-
资助金额:$31.27万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER LIKE PATHOLOGY IN INCLUSION BODY MYOPATHY
-
批准号:6295383
-
项目类别:
-
资助金额:$33.2万
-
财政年份:1999
-
负责人:VALERIE ASKANAS
-
依托单位:
BAPP AND PRION TRANSFECTED HUMAN MUSCLE CULTURES
-
批准号:2609681
-
项目类别:
-
资助金额:$26.73万
-
财政年份:1995
-
负责人:VALERIE ASKANAS
-
依托单位:
BAPP AND PRION TRANSFECTED HUMAN MUSCLE CULTURES
-
批准号:2273225
-
项目类别:
-
资助金额:$19.86万
-
财政年份:1995
-
负责人:VALERIE ASKANAS
-
依托单位:
BAPP AND PRION TRANSFECTED HUMAN MUSCLE CULTURES
-
批准号:2037950
-
项目类别:
-
资助金额:$20.68万
-
财政年份:1995
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER BETA-AMYLOID PROTEIN IN DISEASED HUMAN MUSCLE
-
批准号:2269794
-
项目类别:
-
资助金额:$7.19万
-
财政年份:1993
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER BETA-AMYLOID PROTEIN IN DISEASED HUMAN MUSCLE
-
批准号:2269793
-
项目类别:
-
资助金额:$6.88万
-
财政年份:1993
-
负责人:VALERIE ASKANAS
-
依托单位:
ALZHEIMER BETA-AMYLOID PROTEIN IN DISEASED HUMAN MUSCLE
-
批准号:3418751
-
项目类别:
-
资助金额:$6.6万
-
财政年份:1993
-
负责人:VALERIE ASKANAS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
BCL3介导前列腺癌Lum stem-like细胞干性维持与内分泌治疗抵抗的机制研究
-
批准号:2026JJ70013
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:汤谷雨
-
依托单位:
CDC like kinase 2调控巨噬细胞极化影响脓毒症肝损伤
-
批准号:2026JJ81104
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王剑
-
依托单位:
桂花类胡萝卜素代谢相关新基因OfMYB-like的功能与机制解析
-
批准号:JCZRYB202501133
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
HmWER-like调控花青素影响绣球‘无尽夏’蓝色萼片形成的机制研究
-
批准号:2025JJ50137
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:彭继庆
-
依托单位:
OsbZIP60-like作为锌感受器调控香稻香味的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:包格根
-
依托单位:
MMRN1 通过 EGF-like 结构域参与白血病干细胞干性维持的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:彭美茜
-
依托单位:
社区人群肠道定植肺炎克雷伯菌blaKPC-like
基因介导头孢他啶-阿维巴坦耐药分布及相关
机制研究
-
批准号:Q24H260012
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李娅铃
-
依托单位:
NP63调控Basal-like亚型胰腺导管腺癌特异性增强子通过LAPT5/WWP2/MMC-I轴介导免疫逃逸的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:邹晓平
-
依托单位:
SaCBL1-like–SaCIPK3-1分子模块提高马铃薯耐寒能力的功能和机理研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:陈琳
-
依托单位:
E3泛素连接酶MaXB3-like在乙烯诱导香蕉果实耐冷性中的机制分析
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:卫玮
-
依托单位: